On a Thursday afternoon in September, the sun and the steady creep of the Covid-19 pandemic conspired to keep people off the streets of South Delhi’s posh Greater Kailash 1 (GK1) neighbourhood. S-490, one of the neighbourhood’s many large bungalows, was the exception to this. Inside were close to a dozen people. On the one hand, there were those who had come for the bungalow’s main business—a skincare studio. Scattered amongst them were a second group—patients of Pristyn Care, a new breed of healthcare startup.

The GK1 clinic is emblematic of how Pristyn, which promises smooth elective surgeries for patients, does business. Unlike traditional healthcare setups that incur huge rental, staffing, and equipment costs, the Gurugram-based startup looks to do more with less. 

So, rather than springing for a clinic of its own, Pristyn’s happy to take up a few rooms within a larger business. The resource-sharing goes beyond just space. The skincare studio’s receptionist, for example, also handled Pristyn’s patients.

This approach extends beyond its clinics to the real bread-and-butter of the company—surgeries. After a consultation at one of its clinics, patients deemed to require surgical procedures are operated on by Pristyn’s doctors at third-party hospitals the startup has partnered with. Currently, the company claims to have tied up with 250 hospitals across 14 cities. These range from neighbourhood hospitals to even some within leading healthcare chains such as Apollo.

The company is the brainchild of Harsimarbir Singh, Vaibhav Kapoor, and Garima Sawhney. Kapoor and Sawhney are doctors—a general surgeon and a gynaecologist, respectively. Singh, meanwhile, has a business background. He has co-founded various companies and has also worked as a senior executive at payments company MobiKwik and services marketplace Urban Company.

 In 2018, when Kapoor and Sawhney quit their hospital jobs to start their own clinic, Singh—a close friend of the doctor couple—proposed they start a company. “They did Pristyn’s very first surgeries; I brought the patients,” he says. That approach led to Pristyn conducting 250 surgeries—largely for procedures for haemorrhoids, hernia, fissures, and gynaecological issues—in four months. 

In a day, we would have two patients, and we would do everything to make sure they got a good consultation. If they needed surgery, we would personally accompany them for diagnostic tests, to and from hospitals, processing their insurance and so on.

Harsimarbir Singh, co-founder of Pristyn Care

“Large hospitals that have been in existence for over ten years do close to 300 such surgeries in a month. We achieved that between two surgeons in four months,” he said. 

Pristyn has come a long way in the short time since. It has raised $27 million from a clutch of investors clutch of investors The Economic Times Pristyn Care raises $12 million Series B funding from Sequoia & others Read more , including Sequoia India.

AUTHOR

Maitri Porecha

Maitri writes about everything health for The Ken. For close to 10 years now, she has navigated hospital corridors in her search for a good story. In a past life, when she was not a journalist, she used to teach French at her neighbourhood school. Also an avid fan of forensics, she is always up for decoding mysteries in her free time.

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 5 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 5 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 5 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.